Development of cyclic peptides with potent in vivo osteogenic activity through RaPID-based affinity maturation

Osteoporosis is caused by a disequilibrium between bone resorption and bone formation. Therapeutics for osteoporosis can be divided into antiresorptives that suppress bone resorption and anabolics which increase bone formation. Currently, the only anabolic treatment options are parathyroid hormone m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashiruddin, Nasir K., Hayashi, Mikihito, Nagano, Masanobu, Wu, Yan, Matsunaga, Yukiko, Takagi, Junichi, Nakashima, Tomoki, Suga, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733813/
https://www.ncbi.nlm.nih.gov/pubmed/33229551
http://dx.doi.org/10.1073/pnas.2012266117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733813/
https://www.ncbi.nlm.nih.gov/pubmed/33229551
http://dx.doi.org/10.1073/pnas.2012266117

Ejemplares similares